Objective: to assess the efficacy and safety of type TECA hybrid artificial liver support system (HALSS) to treat patients with acute liver failure (ALF).
目的：观察teca型组合型人工肝支持系统(HALSS)治疗急性肝功能衰竭(alf)患者的有效性和安全性。
Conclusions the hybrid artificial liver support system has prominent liver support effects for hepatic failure, which can be regarded as an efficient measure for the treatment of severe hepatitis.
结论所建混合生物人工肝支持系统对肝衰竭有明显的肝支持作用，可作为重型肝炎的有效治疗手段。
Conclusions the hybrid artificial liver support system has prominent liver support effects for hepatic failure, which can be regarded as an efficient measure for the treatment of severe hepatitis.
结论所建混合生物人工肝支持系统对肝衰竭有明显的肝支持作用，可作为重型肝炎的有效治疗手段。
应用推荐